Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Dmitri, Iarikov"'
Autor:
Mayurika Ghosh, Dmitri Iarikov, Xiaojing (Karen) Qi, Daniel Rubin, Simone Shurland, Avery Goodwin, Xiaohui Wei, Dakshina Chilukuri, Owen McMaster, Terry Miller, Peter Kim, Adam Sherwat
Publikováno v:
Emerging Infectious Diseases, Vol 30, Iss 11, Pp 2227-2230 (2024)
The US Food and Drug Administration recognizes the unmet medical need for antibacterial drugs to treat serious bacterial diseases caused by resistant pathogens for which effective therapies are limited or lacking. The agency also recognizes that desi
Externí odkaz:
https://doaj.org/article/bea93d0df6aa4e96b97145aac78ce7ee
Autor:
Xiaohui, Wei, Shabnam, Naseer, Edward A, Weinstein, Dmitri, Iarikov, Sumathi, Nambiar, Kellie S, Reynolds, Seong H, Jang
Publikováno v:
Clinical Pharmacology & Therapeutics. 112:1004-1007
In this report, we describe our scientific approach for including effluent flow rate (Q
Autor:
Kalavati Suvarna, Daniel B. Rubin, Seong H. Jang, Sumathi Nambiar, John Farley, Edward A. Weinstein, Karen Higgins, Dmitri Iarikov, Xiaohui Wei, Shabnam Naseer, Avery Goodwin
Publikováno v:
Clinical Infectious Diseases. 72:e1103-e1111
In November 2019, the Food and Drug Administration (FDA) approved cefiderocol for the treatment of complicated urinary tract infections (cUTI) including pyelonephritis caused by susceptible gram-negative bacteria in adults with limited to no alternat
Publikováno v:
Antimicrob Agents Chemother
In 2018, the FDA approved plazomicin for the treatment of complicated urinary tract infections (cUTI) including pyelonephritis in adult patients with limited or no alternative treatment options. The objective of this article is to provide the scienti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc2d07787ab51cb43b6e8aae9fc43f46
https://europepmc.org/articles/PMC9017347/
https://europepmc.org/articles/PMC9017347/
Autor:
Abhay Joshi, Jürgen B. Bulitta, Binh An Diep, John Farley, Alexander J. Lepak, Ursula Waack, James M Byrne, Thomas J. Walsh, Edward A. Weinstein, Andrew J Phipps, Lynn Miesel, Dmitri Iarikov, Matthew B. Lawrenz, Simone M Shurland, Brian Luna, William W. Hope, Tina Guina, Thushi Amini, William J. Weiss
Publikováno v:
Antimicrob Agents Chemother
The U.S. Food and Drug Administration (FDA) hosted a public workshop entitled “Advancing Animal Models for Antibacterial Drug Development” on 5 March 2020. The workshop mainly focused on models of pneumonia caused by Pseudomonas aeruginosa and Ac
Autor:
Claudia Martorell, Robert P. Hoffman, Dmitri Iarikov, Daniel J. Skiest, Melina Irizarry-Acosta
Publikováno v:
Journal of the International Association of Physicians in AIDS Care. 9:227-231
Most studies of primary antiretroviral (ARV) resistance have been conducted in large metropolitan areas with reported rates of 8% to 25%. We collected data on 99 HIV-1-infected antiretroviral-naive patients from several sites in Springfield, MA, who
Autor:
James V. Lynskey, Faheem A. Sandhu, Marietta McAtee, Dmitri Iarikov, Barbara S. Bregman, Jean-Valery Coumans, Haining Dai
Publikováno v:
Topics in Spinal Cord Injury Rehabilitation. 8:52-68
Spinal cord injury (SCI) removes descending input to spinal cord circuitry and results in loss of function below the level of injury. Interventions designed to increase the intrinsic capacity of CNS neurons for growth and other interventions to creat
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 59(8)
Hypoglycemia was not previously known to be a linezolid-associated adverse reaction. A case report describing symptomatic hypoglycemia in a linezolid recipient prompted a review of the US Food and Drug Administration Adverse Event Reporting System, w
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 55(11)
Background. Addition of antibacterial drugs to interim antibacterial cement spacers (ACSs) is considered to be standard of care for surgical revision in prosthetic joint infections (PJIs). We reviewed published studies evaluating the choice and doses
Autor:
Robert P. Hoffman, Carol A. Rauch, Claudia Martorell, Dmitri Iarikov, Daniel J. Skiest, Melina Irizarry-Acosta
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 53(3)
Background: HIV-1 genotypic resistance testing is not routinely recommended for patients who have been off antiretroviral therapy (ART) for longer than 4 weeks. We assessed the results and use of resistance testing in patients off ART. Methods: All H